Stimulation of ICa by basal PKA activity is facilitated by caveolin-3 in cardiac ventricular myocytes

J Mol Cell Cardiol. 2014 Mar;68(100):47-55. doi: 10.1016/j.yjmcc.2013.12.026. Epub 2014 Jan 9.

Abstract

L-type Ca channels (LTCC), which play a key role in cardiac excitation-contraction coupling, are located predominantly at the transverse (t-) tubules in ventricular myocytes. Caveolae and the protein caveolin-3 (Cav-3) are also present at the t-tubules and have been implicated in localizing a number of signaling molecules, including protein kinase A (PKA) and β2-adrenoceptors. The present study investigated whether disruption of Cav-3 binding to its endogenous binding partners influenced LTCC activity. Ventricular myocytes were isolated from male Wistar rats and LTCC current (ICa) recorded using the whole-cell patch-clamp technique. Incubation of myocytes with a membrane-permeable peptide representing the scaffolding domain of Cav-3 (C3SD) reduced basal ICa amplitude in intact, but not detubulated, myocytes, and attenuated the stimulatory effects of the β2-adrenergic agonist zinterol on ICa. The PKA inhibitor H-89 also reduced basal ICa; however, the inhibitory effects of C3SD and H-89 on basal ICa amplitude were not summative. Under control conditions, myocytes stained with antibody against phosphorylated LTCC (pLTCC) displayed a striated pattern, presumably reflecting localization at the t-tubules. Both C3SD and H-89 reduced pLTCC staining at the z-lines but did not affect staining of total LTCC or Cav-3. These data are consistent with the idea that the effects of C3SD and H-89 share a common pathway, which involves PKA and is maximally inhibited by H-89, and suggest that Cav-3 plays an important role in mediating stimulation of ICa at the t-tubules via PKA-induced phosphorylation under basal conditions, and in response to β2-adrenoceptor stimulation.

Keywords: Ca; Phosphorylation; t-tubules; β(2)-Adrenoceptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology
  • Adrenergic beta-2 Receptor Agonists / pharmacology
  • Animals
  • Calcium Channels, L-Type / metabolism
  • Calcium Signaling*
  • Caveolin 3 / metabolism*
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / metabolism*
  • Ethanolamines / pharmacology
  • Heart Ventricles / cytology*
  • Isoquinolines / pharmacology
  • Male
  • Myocytes, Cardiac / enzymology*
  • Patch-Clamp Techniques
  • Phosphorylation
  • Protein Binding
  • Protein Kinase Inhibitors / pharmacology
  • Protein Processing, Post-Translational
  • Rats
  • Rats, Wistar
  • Sarcolemma / enzymology
  • Sulfonamides / pharmacology

Substances

  • Adrenergic beta-2 Receptor Agonists
  • Calcium Channels, L-Type
  • Cav3 protein, rat
  • Caveolin 3
  • Ethanolamines
  • Isoquinolines
  • Protein Kinase Inhibitors
  • Sulfonamides
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • zinterol
  • Cyclic AMP-Dependent Protein Kinases
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide